Stem cell therapy market to grow at ~11% CAGR, reaching $58.5B by 2034 due to tech and regulatory advances

The global stem cell therapy market is projected to expand at a compound annual growth rate (CAGR) of approximately 11% from 2026 to 2034, reaching a market size of $58.5 billion. Growth is driven by rising demand for regenerative medicine to treat chronic diseases like cancer, diabetes, and neurological disorders, alongside technological advancements and supportive regulatory frameworks. North America leads the market due to advanced healthcare infrastructure and investments, while Asia-Pacific and Europe also show strong growth fueled by government initiatives and clinical trials. Key recent developments include Japan's approval of iPSC-based therapies and new product launches in India, highlighting ongoing innovation and commercialization in the sector.